Title:
MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST
Document Type and Number:
WIPO Patent Application WO2005019167
Kind Code:
A3
Abstract:
Novel compounds, or pharmaceutically-acceptable salts, tautomers or prodrugs thereof, of Formula (I) wherein A, W, X, Z, R<1>-R<3>, and R<8> are as defined in the specification, are provided. Also provided are methods of treating or preventing a melanin concentrating hormone-mediated disorder in a subject, comprising administering to a subject in need of such treatment or prevention a compound of Formula (I).
Inventors:
HULME CHRISTOPHER (GB)
TEMPEST PAUL (US)
MA VU (US)
NIXEY THOMAS (US)
BALOW GUITY (US)
TEMPEST PAUL (US)
MA VU (US)
NIXEY THOMAS (US)
BALOW GUITY (US)
Application Number:
PCT/US2004/026021
Publication Date:
December 01, 2005
Filing Date:
August 11, 2004
Export Citation:
Assignee:
AMGEN INC (US)
HULME CHRISTOPHER (GB)
TEMPEST PAUL (US)
MA VU (US)
NIXEY THOMAS (US)
BALOW GUITY (US)
HULME CHRISTOPHER (GB)
TEMPEST PAUL (US)
MA VU (US)
NIXEY THOMAS (US)
BALOW GUITY (US)
International Classes:
A61K31/4025; A61K31/495; A61K31/496; A61K31/66; A61K31/675; C07D257/04; C07D401/14; C07D403/06; C07D; (IPC1-7): A61K31/496; C07D401/14; C07D403/06
Domestic Patent References:
WO2002004433A2 | 2002-01-17 |
Other References:
See also references of EP 1653960A4
Download PDF:
Previous Patent: METHOD OF TARGETING A THERAPEUTIC AGENT
Next Patent: FLUORINATED LYSINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS
Next Patent: FLUORINATED LYSINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS